D-lactate test in spinal fluid for suspected ventriculostomy-related meningitis
Official title: Diagnostic Significance of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis : a Pilot Study
Run by University Hospital, Toulouse · NCT06482463 · Data updated 2026-11-12
This will test whether measuring D-lactate in cerebrospinal fluid helps diagnose meningitis in adults with an external ventriculostomy who are suspected of having a hospital-acquired infection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 185 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | February 12, 2025 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT06482463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) at Toulouse University Hospital who have an external ventriculostomy and are currently suspected of having ventriculostomy-related nosocomial meningitis are eligible.
✕Probably not a fit
Patients with community-acquired meningitis, recent meningitis within the past month, severe renal failure or on peritoneal dialysis, short bowel syndrome, or those already diagnosed elsewhere are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center study in the neurosurgical ICU at Toulouse University Hospital collects an extra cerebrospinal fluid (CSF) sample when clinicians perform routine sampling for suspected ventriculostomy-related nosocomial meningitis. Samples are frozen at -80°C and will undergo serial assays for D‑lactate, procalcitonin (PCT), and pro-inflammatory cytokines (IL-1, IL-6, IL-8, TNFα). If the initial CSF does not meet diagnostic criteria, a second sample is taken 48–96 hours later; final clinical classification of meningitis versus no meningitis is made retrospectively by two neurosurgical intensivists using the medical record. Participants are followed through an end-of-participation visit at four weeks.
Why it matters
Potential benefit: If successful, the D‑lactate test could provide a faster and more specific CSF marker to distinguish ventriculostomy-related meningitis from noninfectious inflammation, helping guide timely antibiotic decisions.
How similar studies have gone: CSF procalcitonin and cytokine measurements have some supporting data for diagnosing nosocomial meningitis, but using D‑lactate in CSF for ventriculostomy-related meningitis is relatively novel with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ⩾ 18 years. * Patient with an external ventriculostomy implanted at the Toulouse University Hospital. * Patient suspected of nosocomial meningitis due to a febrile syndrome (in the absence of any other identified infectious site), headache, nausea, lethargy, change in neurological status, meningeal syndrome, epileptic event and cutaneous or subcutaneous inflammation at the ventriculostomy site of insertion. * Patient having expressed oral consent, after free and informed information. * Patient affiliated to a social security scheme. Exclusion Criteria: * Diagnosis of community meningitis. * Proven or suspected meningitis and/or ventriculitis during the previous month. * Diagnosis of nosocomial meningitis made in another medical centre prior to admission. * Short bowel syndrome. * Acute mesenteric ischaemia. * End-stage renal failure (GFR \< 15 ml/min/m2). * Peritoneal dialysis. * Patient participating in another research protocol with an exclusion period still in progress. * Pregnant or breastfeeding woman. * Patient under guardianship or trusteeship, persons placed under the protection of justice
Where it's running
-
Toulouse Hospital
Toulouse, France Recruiting
Study contacts
- Study coordinator: Lucie LELIEVRE, Md
- Email: lelievre.l@chu-toulouse.fr
- Phone: 0561777198
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating factors related to Clostridioides difficile infection recurrence
This study is trying to find out how certain body factors, like gut bacteria and genetics, affect the chances of Clostridioides difficile infection coming back in adults who have already been diagnosed with it.
-
Rapid test for Candida auris detection in hospital patients
This study tests a quick rapid diagnostic test to see if it can correctly identify Candida auris in patient samples compared with the standard lab method.
-
Understanding hospital-acquired respiratory virus infections
This study is trying to learn more about respiratory virus infections that people catch in hospitals and see how vaccines might help prevent them.
-
Postoperative pneumonia after coronary artery bypass grafting
This project will see if adults who develop non-ventilator hospital-acquired pneumonia after coronary artery bypass grafting have worse cardiopulmonary outcomes in the year after surgery than those who do not.
-
Improving oral care to prevent pneumonia in COPD patients in the ICU
This study is testing if better oral care can help prevent pneumonia in COPD patients who are in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.